Cluster I was characterized by enrichment of mutations in IDH1 (52%, FDR = 1.42 × 10−8) and ATRX (27%, FDR = 0.0232), consistent with their predominance in glioma samples (28). The gene discussed is ATRX; the disease is central nervous system cancer.